Biodefense Market Demand 2022-2030: Increasing Investment from Pharmaceutical Companies to Develop Vaccines to Prevent Bio Threats Is Expected to Drive Industry Revenue Growth

The global biodefense market size is expected to reach USD 32.80 Billion in 2030 and register a revenue CAGR of 8.7% over the forecast period, according to latest report by Reports and Data. Steady revenue growth of the biodefense market can be attributed to several factors, such as supportive government initiatives, rapid technological advancements, and rising awareness about biological threats. However, low market penetration in developing and underdeveloped countries may hinder market revenue growth during the forecast period.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1410

Biodefense comprises interventions, such as vaccines, drugs, and surveillance of pathogens, along with extensive R&D activities and community health preparations, to prevent bioterrorism. An ideal biodefense vaccine platform would allow for quick formulation of novel vaccines in response to emerging or engineered pathogens.

Various countries have adopted goals for eradicating epidemics of AIDS, tuberculosis, and malaria, and combat hepatitis, water-borne diseases, and other communicable diseases, and vaccines play a crucial role in achieving these goals within a set period of time. Therefore, governments across the world, through various awareness programs, have been focusing on providing vaccines, especially to children at a very young age, at regular intervals to protect them from several biological pathogens. Growing interest of governments of various countries in immunization is expected to drive market growth over the forecast period. Government legislations, such as Project Bioshield, offer countermeasures against chemical, radiological, nuclear, and biological attacks, and provide accessible biological countermeasures for targeting various strains of smallpox and anthrax.

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.

Top Companies Profiled in the Report:

 

Altimmune Inc., Emergent BioSolutions Inc., SIGA Technologies Inc., Ichor Medical Systems Inc., Elusys Therapeutics Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies Corporation, Ology Bioservices Inc., Dynport Vaccine Company LLC, and Cleveland Biolabs Inc.

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/biodefense-market

Some Key Highlights from the Report

  • Among product type segments, anthrax vaccine segment accounted for largest revenue share in 2021, which can be attributed to increasing spending by governments across the globe to develop and store sufficient anthrax vaccines. Anthrax is primarily caused by ‘Bacillus anthracis’ bacterium and is an extremely life-threatening disease. Hence, its vaccine has been a life-saver and is given to individuals in the age group of 18-65 years, who are at a high risk of exposure to anthrax.
  • Among application segments, the civilian segment accounted for largest revenue share in 2021 and is expected to register a faster revenue CAGR during the forecast period, owing to rising biological threats to civilians from terrorist organizations. It is observed that terrorist activities disturb peace and prosperity in a country to destabilize the government, and terrorist organizations can use biological agents, which is a lethal option to harm citizens of a country. Rising initiatives by governments in various countries to develop health infrastructure to accommodate a large number of people at a time of emergency is expected to drive segment revenue growth during the forecast period.
  • Biodefense Market in North America accounted for largest revenue share in 2021. Growth of this regional market is attributed to high federal funding for biodefense, technological advancements, and growing awareness among population in the region. Presence of major players in the region is also a favorable factor expected to support market growth. Strategies to establish biodefense mechanism aim to detect and contain biothreats at their source, and support and promote biomedical innovation and improve emergency response in case of a biological outbreak.
  • Biodefense market in Asia-Pacific is expected to register a faster revenue CAGR during the forecast period, due to surging investments in R&D. In addition to this, growing incidents of biothreats is also driving biodefense market growth in the region. Governments of countries in the region are supporting market growth by subsidizing companies with adequate funding and easy clearance of licenses for establishing factories and manufacturing plants for vaccines and drugs, which is expected to drive  market revenue growth in Asia-Pacific.

Download Summary @ https://www.reportsanddata.com/download-summary-form/1410

Biodefense Market Segmentation:

Product Type Outlook (Revenue, USD Billion; 2019–2030)

  • Anthrax Vaccine
  • Smallpox Vaccine
  • Botulism Vaccine
  • Radiation Vaccine
  • Others

Application Outlook (Revenue, USD Billion; 2019–2030)

  • Military
  • Civilian

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1410

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Explore Latest Trending Research Reports By Reports and Data's:

Bioinformatics Services Market By Service Type (Sequencing Services, Data Analysis Services, Drug Discovery Services, Differential Gene Expression Analysis, Database Management Services, and Others), By Application, and By End User And Segment Forecasts, 2020-2028

Biological Safety Testing Market By Product (Reagents & Kits, Instruments, Services), By Application (Vaccines & Therapeutics, Stem Cell, Tissue & Tissue-Based Products, Gene Therapy, Blood & Blood-Based Therapy), By Test Type, And Segment Forecasts to 2028

Medical Marijuana Market , By Product Type (Oil, Buds, and Tinctures), By Route of Administration (Inhalation, Oral, Intravenous, and Topical), By Application, By Distribution Channel, and By Region Forecast to 2028

Cancer Stem Cell Therapeutics Market Analysis, By Treatment Type (Autologous Stem Cell Transplants, Allogeneic Stem Cell Transplants), Disease Type (Breast Cancer, Lung Cancer), By Application Type (Musculoskeletal disorders, Plasma Cell disorders, Forecasts to 2028

Extremities (Shoulder and Small Joint Implants) Market Analysis, By Product Type (Upper Extremity Devices, Lower Extremity Devices), By Material (Ceramics, Metallic, Polymeric), By End Use (Hospitals, Ambulatory Surgical Centres, Orthopedic Clinics, Others), Forecasts to 2028

 

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Back to news